Headache and Migraine

Latest News

Latest Videos

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 Score

Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 Score

Paul Durham, PhD: A Combination Approach With nVNS in Migraine

Paul Durham, PhD: A Combination Approach With nVNS in Migraine

Paul Durham, PhD: Noninvasive Vagus Nerve Stimulation

Paul Durham, PhD: Noninvasive Vagus Nerve Stimulation

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

Rebecca Stainman, MD: Identifying, Addressing Physician Burnout

Rebecca Stainman, MD: Identifying, Addressing Physician Burnout

Nina Riggins, MD, PhD: Predicting Outcomes of Botox Treatment in Chronic Migraine

Nina Riggins, MD, PhD: Predicting Outcomes of Botox Treatment in Chronic Migraine

Jelena Pavlovic, MD, PhD: Perimenstrual-Related Migraine

Jelena Pavlovic, MD, PhD: Perimenstrual-Related Migraine

Alon Ironi: Nerivio Migra Reduces Excess Medication Use in Migraine

Alon Ironi: Nerivio Migra Reduces Excess Medication Use in Migraine

CME Content

4th Women in Neurology Conference

In-Person Event

4th Women in Neurology Conference

October 24-26, 2025

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

Carrie M. Hersh, DO, MSc, FAAN; Anna Shah, MD

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

James F. Howard Jr, MD; Nicholas J. Silvestri, MD, FAAN; Neelam Goyal, MD

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

Alireza Atri, MD, PhD; Erik S. Musiek, MD, PhD; Malú Gámez Tansey, PhD

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

Ilan Melnick, MD; Alejandro Alva, MD; Linda Trinh, DNP, PMHNP, FNP, MPH

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

October 31, 2025

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

In-Person + Virtual Event

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

November 21, 2025

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

John F. Brandsema, MD; Abigail N. Schwaede, MD; Samuel J. Mackenzie, MD, PhD

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

James F. Howard Jr, MD

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

John Brandsema, MD; Neelam Goyal, MD

Identifying and Treating CIDP in the Modern Era

Identifying and Treating CIDP in the Modern Era

Jeffrey A. Allen, MD; Karissa L. Gable, MD

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

John Brandsema, MD; Carla D. Zingariello, DO

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Estelamari Rodriguez, MD, MPH; Millie Das, MD; Ruham Nasany, MD

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Anne Chiang, MD, PhD; J. Douglas Miles, MD, PhD, FAAN; Suma Satti, MD

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Abigail N. Schwaede, MD; Emmanuelle (Noelle) Tiongson, MD

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

Shamik Bhattacharyya, MD, MS, FAAN; Mirla Avila, MD; Dean Wingerchuk, MD

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

Richard Bedlack, MD, PhD

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Terry Heiman-Patterson, MD

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

More News

Ubrogepant: Treatment for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Rimegepant: Treatment for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Patient Selection for Acute Migraine Therapy

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Acute Migraine Treatment Goals

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Treatment Goals for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Treating Acute Migraine in the Community Setting

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Acute Migraine Treatment: What’s Next?

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Real-World Experience With Gepants for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Gepants for Acute Migraine: Patient Management

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Gepants for Acute Migraine: Safety & Efficacy Data

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Advances in the Treatment of Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Burden of Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Jennifer Frontera, MD: Neurologic Implications of COVID-19 Infection

ByJennifer Frontera, MD

October 30th 2020

The professor of neurology at the NYU Langone Grossman School of Medicine gave her reaction to the data she and colleagues published on neurologic disorders in patients with COVID-19.

Behavioral and Lifestyle Strategies for Migraine Management

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Patient Selection for Neuromodulation Devices

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Role of Neuromodulation for Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Patient Selection of Novel Therapies for Migraine Treatment

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Intranasal DHE in Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Safety of CGRP Receptor Antagonists vs 5-HT1F Agonists

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Use of 5-HT1F Agonists in Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Acute Treatment of Migraine: Progress With Novel Medications

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Evolution of Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Acute Treatment of Migraine: Traditional Therapies

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Unmet Needs in the Management of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Nerivio Device Granted Clearance for Acute Treatment of Chronic Migraine

October 26th 2020

The Theranica Biotherapeutics remote electrical neuromodulation device is now cleared for the acute treatment of migraine with or without aura in adults, without limitation to episodic migraine.

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni

Inside the Phase 3 MASCOT Trial: Lundbeck’s Push for the First Disease-Modifying MSA Therapy

FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology

Reinforce Ocrelizumab’s Role Across the Full Spectrum of More Advanced Progressive MS: Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath

Overviewing Phase 3 OPERETTA 2 Trial and Ocrelizumab’s Impact on Pediatric Multiple Sclerosis: Brenda Banwell, MD, FRCPC, FAAN

© 2025 MJH Life Sciences^®

All rights reserved.